Key Takeaways
- • Cryptonews published a 2026 buyer's guide ranking 12 crypto futures trading platforms after testing more than 40 providers, with PrimeXBT named overall best and Kraken, Coinbase, MEXC, Binance, and others profiled.
- • The guide reports maximum leverage ranging from 50x (Coinbase) to 500x (PrimeXBT and MEXC), with maker fees from 0% (MEXC, KCEX) to 0.02% across most listed exchanges.
- • Daily futures volumes cited range from roughly $457 million (Margex) to about $30 billion (Binance), according to the guide's comparison table.
- • The article flags that most offshore futures platforms are unavailable to US residents and that PrimeXBT lacks a MiCA license, limiting access for many EU/EEA users.
- • The ranking methodology weights supported contracts and security/reputation at 25% each, followed by trading fees (20%), leverage (15%), and user experience (15%).
Summary
The comparison table in the guide lists trading pairs, instruments, maximum leverage, maker/taker fees, and daily futures volume for each exchange. PrimeXBT is ranked first overall, offering more than 30 crypto perpetual contracts, maximum leverage of up to 500x, maker fees of 0.01%, and taker fees of 0.02% to 0.045% based on volume tiers. The article notes that PrimeXBT holds licenses from South Africa's FSCA, the Seychelles FSA, and El Salvador's BCR, but lacks a MiCA license and is generally restricted for EU/EEA users. Kraken is recommended for regulatory compliance, with more than 350 perpetual markets, 100x leverage on BTC and ETH, and daily futures volume of about $816 million according to the guide. Coinbase is cited as a regulated option for US and global traders, with 50x maximum leverage and approximately $8.5 billion in daily futures volume.
The guide's methodology assigns 25% weight to supported futures contracts, 25% to security and reputation, 20% to trading fees, 15% to leverage allowance, and 15% to user experience. Other platforms in the list include MEXC, Binance, LBank, Bitbase, Margex, OKX, BingX, Bybit, and KCEX. The article is a commercial review guide and its rankings reflect the publisher's own testing criteria rather than independent regulatory assessment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.